OBJECTIVE: To test whether beta carotene supplementation affects the incidence of age-related maculopathy (ARM) in a large-scale randomized trial. DESIGN: Randomized, double-masked, placebo-controlled trial among 22 071 apparently healthy US male physicians aged 40 to 84 years. Participants were randomly assigned to receive beta carotene (50 mg every other day) or placebo. Main Outcome Measure Incident ARM responsible for a reduction in best-corrected visual acuity to 20/30 or worse. RESULTS: After 12 years of treatment and follow-up, there were 162 cases of ARM in the beta carotene group vs 170 cases in the placebo group (relative risk [RR], 0.96; 95% confidence interval [CI], 0.78-1.20). The results were similar for the secondary end points of ARM with or without vision loss (275 vs 274 cases; RR, 1.01; 95% CI, 0.86-1.20) and advanced ARM (63 vs 66 cases; RR, 0.97; 95% CI, 0.69-1.37). CONCLUSIONS: These randomized data relative to 12 years of treatment among a large population of apparently healthy men indicate that beta carotene supplementation has no beneficial or harmful effect on the incidence of ARM. Long-term supplemental use of beta carotene neither decreases nor increases the risk of ARM.
RCT Entities:
OBJECTIVE: To test whether beta carotene supplementation affects the incidence of age-related maculopathy (ARM) in a large-scale randomized trial. DESIGN: Randomized, double-masked, placebo-controlled trial among 22 071 apparently healthy US male physicians aged 40 to 84 years. Participants were randomly assigned to receive beta carotene (50 mg every other day) or placebo. Main Outcome Measure Incident ARM responsible for a reduction in best-corrected visual acuity to 20/30 or worse. RESULTS: After 12 years of treatment and follow-up, there were 162 cases of ARM in the beta carotene group vs 170 cases in the placebo group (relative risk [RR], 0.96; 95% confidence interval [CI], 0.78-1.20). The results were similar for the secondary end points of ARM with or without vision loss (275 vs 274 cases; RR, 1.01; 95% CI, 0.86-1.20) and advanced ARM (63 vs 66 cases; RR, 0.97; 95% CI, 0.69-1.37). CONCLUSIONS: These randomized data relative to 12 years of treatment among a large population of apparently healthy men indicate that beta carotene supplementation has no beneficial or harmful effect on the incidence of ARM. Long-term supplemental use of beta carotene neither decreases nor increases the risk of ARM.
Authors: I-Min Lee; Nancy R Cook; J Michael Gaziano; David Gordon; Paul M Ridker; Joann E Manson; Charles H Hennekens; Julie E Buring Journal: JAMA Date: 2005-07-06 Impact factor: 56.272
Authors: Scott M Lippman; Phyllis J Goodman; Eric A Klein; Howard L Parnes; Ian M Thompson; Alan R Kristal; Regina M Santella; Jeffrey L Probstfield; Carol M Moinpour; Demetrius Albanes; Philip R Taylor; Lori M Minasian; Ashraful Hoque; Sarah Moody Thomas; John J Crowley; J Michael Gaziano; Janet L Stanford; Elise D Cook; Neil E Fleshner; Michael M Lieber; Philip J Walther; Fadlo R Khuri; Daniel D Karp; Gary G Schwartz; Leslie G Ford; Charles A Coltman Journal: J Natl Cancer Inst Date: 2005-01-19 Impact factor: 13.506
Authors: Stephan Michels; Philip J Rosenfeld; Carmen A Puliafito; Erin N Marcus; Anna S Venkatraman Journal: Ophthalmology Date: 2005-06 Impact factor: 12.079
Authors: Evangelos S Gragoudas; Anthony P Adamis; Emmett T Cunningham; Matthew Feinsod; David R Guyer Journal: N Engl J Med Date: 2004-12-30 Impact factor: 91.245
Authors: Gary E Goodman; Mark D Thornquist; John Balmes; Mark R Cullen; Frank L Meyskens; Gilbert S Omenn; Barbara Valanis; James H Williams Journal: J Natl Cancer Inst Date: 2004-12-01 Impact factor: 13.506
Authors: C H Hennekens; J E Buring; J E Manson; M Stampfer; B Rosner; N R Cook; C Belanger; F LaMotte; J M Gaziano; P M Ridker; W Willett; R Peto Journal: N Engl J Med Date: 1996-05-02 Impact factor: 91.245
Authors: William G Christen; Robert J Glynn; Howard D Sesso; Tobias Kurth; Jean Macfadyen; Vadim Bubes; Julie E Buring; Joann E Manson; J Michael Gaziano Journal: Ophthalmology Date: 2012-04-13 Impact factor: 12.079
Authors: William G Christen; Robert J Glynn; Joann E Manson; Jean MacFadyen; Vadim Bubes; Miriam Schvartz; Julie E Buring; Howard D Sesso; J Michael Gaziano Journal: Ophthalmology Date: 2013-11-20 Impact factor: 12.079
Authors: William G Christen; Nancy R Cook; JoAnn E Manson; Julie E Buring; Daniel I Chasman; I-Min Lee; Vadim Bubes; Chunying Li; Margarette Haubourg; Debra A Schaumberg Journal: JAMA Ophthalmol Date: 2020-12-01 Impact factor: 7.389